VLA
Click for more information
0.00% $1.75 viralytics limited

Late Breaking News: Phase I/II CANON study: Novel oncolytic...

  1. tewkleberry
    1,858 Posts.
    clock Created with Sketch.
    14/03/16
    12:03
    Post #: 17267147
    Late Breaking News: Phase I/II CANON study: Novel oncolytic immunotherapy for the treatment of Non-Muscle Invasive Bladder Cancer using intravesical CAVATAK (Coxsackievirus A21)

    I wonder if there's any significance in "Late Breaking News"?
    VLA Price at posting: 68.5¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS 29Metals greenlit to release more water from flooded Capricorn mine this wet season
right-arrow Created with Sketch.
NEWS Patronus receives mining approval for Fountain Head
right-arrow Created with Sketch.
NEWS Westpac records 3% fall in net profit for FY24
right-arrow Created with Sketch.
NEWS What each US election outcome would mean for Australian companies & investors
right-arrow Created with Sketch.
NEWS Check out the latest ASX news here!
right-arrow Created with Sketch.
NEWS Ellison slapped with $20M sanction from MinRes but will stay on as leader – for now
right-arrow Created with Sketch.
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.